LEXATUMUMAB
UNII 967Q0SJD77

Substance Identification & Data

This profile provides standardized clinical and technical data for Lexatumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 967Q0SJD77.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 845816-02-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

967Q0SJD77

CAS Registry Number

845816-02-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEXATUMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C64621

National Cancer Institute reference terminology for clinical and research data.

INN ID

8753

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

RR-121

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lexatumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LEXATUMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR TRAIL-R2) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR TRAIL-R2) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5 OR TRAIL-R2)) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B (DEATH RECEPTOR 5 OR TRAIL-R2)) (HUMAN MONOCLONAL HGS-ETR2 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HGS-ETR2 .LAMBDA.-CHAIN, DIMER

LEXATUMUMAB [INN]

LEXATUMUMAB [USAN]

LEXATUMUMAB [WHO-DD]